Symbiosal(®) and lowering of blood pressure and reduced risk of hypertension: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

Following an application from Han‐Biotech GmbH, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EFSA J
Main Authors: Turck, Dominique, Bresson, Jean‐Louis, Burlingame, Barbara, Dean, Tara, Fairweather‐Tait, Susan, Heinonen, Marina, Hirsch‐Ernst, Karen Ildico, Mangelsdorf, Inge, McArdle, Harry J, Naska, Androniki, Neuhäuser‐Berthold, Monika, Nowicka, Grażyna, Pentieva, Kristina, Sanz, Yolanda, Sjödin, Anders, Stern, Martin, Tomé, Daniel, Van Loveren, Henk, Vinceti, Marco, Willatts, Peter, Martin, Ambroise, Strain, Sean (J.J.), Siani, Alfonso
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Scientific Opinion
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7009733/
https://ncbi.nlm.nih.gov/pubmed/32625995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2018.5364
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados